- Home
- FENC vs HRZN Comparison
FENC vs HRZN Comparison
Compare FENC & HRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENC
- HRZN
- Stock Information
- Founded
- FENC 1996
- HRZN 2008
- Country
- FENC United States
- HRZN United States
- Employees
- FENC N/A
- HRZN N/A
- Industry
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- HRZN Finance/Investors Services
- Sector
- FENC Health Care
- HRZN Finance
- Exchange
- FENC Nasdaq
- HRZN Nasdaq
- Market Cap
- FENC 234.9M
- HRZN 251.0M
- IPO Year
- FENC 2001
- HRZN 2010
- Fundamental
- Price
- FENC $8.67
- HRZN $5.87
- Analyst Decision
- FENC Strong Buy
- HRZN Hold
- Analyst Count
- FENC 2
- HRZN 4
- Target Price
- FENC $13.50
- HRZN $7.38
- AVG Volume (30 Days)
- FENC 77.1K
- HRZN 725.5K
- Earning Date
- FENC 11-06-2025
- HRZN 10-28-2025
- Dividend Yield
- FENC N/A
- HRZN 23.42%
- EPS Growth
- FENC N/A
- HRZN N/A
- EPS
- FENC N/A
- HRZN N/A
- Revenue
- FENC $33,302,000.00
- HRZN $97,144,000.00
- Revenue This Year
- FENC $0.18
- HRZN N/A
- Revenue Next Year
- FENC $52.59
- HRZN $9.61
- P/E Ratio
- FENC N/A
- HRZN N/A
- Revenue Growth
- FENC N/A
- HRZN N/A
- 52 Week Low
- FENC $3.96
- HRZN $5.71
- 52 Week High
- FENC $9.92
- HRZN $10.55
- Technical
- Relative Strength Index (RSI)
- FENC 47.99
- HRZN 33.55
- Support Level
- FENC $8.24
- HRZN $5.71
- Resistance Level
- FENC $8.90
- HRZN $6.20
- Average True Range (ATR)
- FENC 0.41
- HRZN 0.17
- MACD
- FENC -0.10
- HRZN 0.01
- Stochastic Oscillator
- FENC 29.24
- HRZN 24.88
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About HRZN Horizon Technology Finance Corporation
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.